Members

Cambridge Cancer Genomics


Member Type: Emerging Biotech/Pharmaceutical Companies

Cambridge Cancer Genomics is an 18-month-old start-up backed by venture capital, with an award-winning history and international recognition from prestigious programs including Y combinator. They are transforming the way cancer patients are treated, through next generation liquid biopsies and smart genomics.

https://www.ccg.ai

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today




Download a Member List

Member List (PDF)